| 2020 | | CANCER CELL LINE FOR EVALUATING PARAPTOSIS, SCREENING METHOD FOR THE PARAPTOSIS INDUCERS AND SCREENING METHOD FOR SENSITIZERS OF PROTEASOME INHIBITORS USING THE SAME | 최경숙 |
| - | | Composition and kit for cancer cell, and method for separating cancer cell using the same | 김유선 |
| 2018 | | Composition comprising expression regulator for preventing or treating non-alcoholic fatty liver | 유민숙, 임인경, 최정아 |
| - | | Composition containing B-cell lymphoma 2 inhibitor for anti-aging and whitening | 강희영, 박태준 |
| - | | Composition for preventing or treating osteoarthritis comprising Neratinib | 김유선, 양시영 |
| - | | Composition for preventing or treating osteoarthritis comprising Selumetinib | 김유선, 양시영 |
| 2016 | | Composition for preventing or treating tumor comprising proteasome inhibitor and dihydropyridine compound | 김인영, 최경숙 |
| 2017 | | Composition for regulating cutaneous pigmentation derived from endothelial cells or secretory factors from endothelial cells and method for screening skin whitening agents | 강희영, 김미선, 박지윤, 박태준 |
| 2018 | | Composition for regulating cutaneous pigmentation or skin whitening comprising SDF1 | 강희영, 김미선, 박태준 |
| 2018 | | Composition for skin whitening comprising clusterin | 강희영, 김미선, 박태준 |
| 2016 | | Composition for treating pigmentary disorder or whitening skin through pleiotrophin modulation | 강희영, 박태준 |
| 2022 | | Compositions and Combination Therapies for Preventing or Treating Cancer comprising Chemokine Inhibitor, Colony Stimulating Factor Inhibitor, and Immune Checkpoint Inhibitor | 김장희, 박태준, 최용원 |
| - | | Compositions and Combination Therapies for Preventing or Treating Cancer comprising Chemokine Inhibitor, Colony Stimulating Factor Inhibitor, and Immune Checkpoint Inhibitor | 김장희, 박태준, 최용원 |
| - | | Cosmetic Composition for Prevention of Skin Senescence | 김홍석, 유민숙, 임인경, 최옥란 |
| 2019 | | Increasing red muscle mass through TIS21 gene expression | 유민숙, 임인경 |
| 2015 | | Kit and method for diagnosis of cell senescence | 김유미, 변해옥, 우현구, 윤계순 |
| 2017 | | MARCH5 K40/54R mutant protein maintaining MARCH5 activity and increasing protein stability | 김송희, 박용예, 유영석, 조혜성 |
| 2017 | | Method for screening anticancer supplement agents inducing RIP3 expression for enhancing sensitivity to anticancer agents and method for monitoring sensitivity to anticancer agents | 구기방, 김유선 |
| 2015 | | Method for screening modulator of RIG-I mediated immune response via stabilization of MARCH5 expression | 김송희, 박용예, 유영석, 조혜성 |
| 2015 | | Method for screening therapeutic agent of liver cancer by inducing HBx degradation via stabilization of MARCH5 expression | 박용예, 조혜성 |
